Trelegy ellipta 100-62.5-25 60S

Ended Awarded Last action

Contract number
SPE2DR26FB2W8
Awardee
Awarding agency
Obligated
$14,068

Award facts

Contract value 100% obligated
$14,067.79 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $14,067.79 delivery order to Amerisourcebergen Drug Corp on April 21, 2026, for Trelegy Ellipta 100-62.5-25 inhalant medication (60-unit supply), with an ultimate completion date of April 22, 2026.

The order is firm fixed price with no set-aside. Place of performance is Conshohocken, PA. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and operates as a pharmaceutical distributor and medical supplier to the Department of Defense and federal healthcare systems under full-and-open competitive awards.

Quick answers

Who was awarded contract SPE2DR26FB2W8?

SPE2DR26FB2W8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 21, 2026.

How much is contract SPE2DR26FB2W8 worth?

The government has obligated $14,068 on SPE2DR26FB2W8.

Is contract SPE2DR26FB2W8 an order under another contract?

Yes. SPE2DR26FB2W8 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.

Was contract SPE2DR26FB2W8 competed?

The extent of competition for SPE2DR26FB2W8 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award